Shandong Boan Biotechnology Statistics

Total Valuation

Shandong Boan Biotechnology has a market cap or net worth of HKD 5.31 billion. The enterprise value is 5.83 billion.

Market Cap	5.31B
Enterprise Value	5.83B

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Shandong Boan Biotechnology has 535.93 million shares outstanding. The number of shares has increased by 1.06% in one year.

Shares Outstanding	535.93M
Shares Change (YoY)	+1.06%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.95%
Owned by Institutions (%)	0.43%
Float	186.29M

Valuation Ratios

The trailing PE ratio is 75.92.

PE Ratio	75.92
Forward PE	n/a
PS Ratio	6.52
PB Ratio	3.37
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 84.28, with an EV/FCF ratio of -51.94.

EV / Earnings	87.82
EV / Sales	7.54
EV / EBITDA	84.28
EV / EBIT	273.67
EV / FCF	-51.94

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.48.

Current Ratio	1.35
Quick Ratio	0.93
Debt / Equity	0.48
Debt / EBITDA	10.28
Debt / FCF	-6.34
Interest Coverage	0.97

Financial Efficiency

Return on equity (ROE) is 4.58% and return on invested capital (ROIC) is 0.68%.

Return on Equity (ROE)	4.58%
Return on Assets (ROA)	0.53%
Return on Capital (ROIC)	0.68%
Revenue Per Employee	995,450
Profits Per Employee	85,473
Employee Count	813
Asset Turnover	0.31
Inventory Turnover	1.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-41.14%
50-Day Moving Average	9.27
200-Day Moving Average	10.28
Relative Strength Index (RSI)	59.86
Average Volume (20 Days)	477,942

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shandong Boan Biotechnology had revenue of HKD 773.46 million and earned 66.41 million in profits. Earnings per share was 0.13.

Revenue	773.46M
Gross Profit	573.11M
Operating Income	21.31M
Pretax Income	66.16M
Net Income	66.41M
EBITDA	65.25M
EBIT	21.31M
Earnings Per Share (EPS)	0.13

Full Income Statement

Balance Sheet

The company has 184.95 million in cash and 711.58 million in debt, giving a net cash position of -526.64 million or -0.98 per share.

Cash & Cash Equivalents	184.95M
Total Debt	711.58M
Net Cash	-526.64M
Net Cash Per Share	-0.98
Equity (Book Value)	1.50B
Book Value Per Share	2.94
Working Capital	207.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -42.92 million and capital expenditures -69.38 million, giving a free cash flow of -112.29 million.

Operating Cash Flow	-42.92M
Capital Expenditures	-69.38M
Free Cash Flow	-112.29M
FCF Per Share	-0.21

Full Cash Flow Statement

Margins

Gross margin is 74.10%, with operating and profit margins of 2.76% and 8.59%.

Gross Margin	74.10%
Operating Margin	2.76%
Pretax Margin	8.55%
Profit Margin	8.59%
EBITDA Margin	8.44%
EBIT Margin	2.76%
FCF Margin	-14.52%

Dividends & Yields

Shandong Boan Biotechnology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.06%
Shareholder Yield	-1.06%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shandong Boan Biotechnology has an Altman Z-Score of 3.28.

Altman Z-Score	3.28
Piotroski F-Score	n/a